Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	New Amedeo service: Amedeo COVID-19 (formerly 2019-nCoV) Weekly publication summary

Hepatitis C

Free Subscription Articles published in Am J Gastroenterol Retrieve available abstracts of 35 articles: HTML format Text format

Single Articles

December 2019
1. MORALES-ARRAEZ D, Hernandez-Guerra M
   Electronic Alerts as a Simple Method for Amplifying the Yield of Hepatitis C Virus Infection Screening and Diagnosis.
   Am J Gastroenterol. 2019 Dec 11. doi: 10.14309/ajg.0000000000000487.
   PubMed     Text format    
   
   
   May 2019
2. PEARLMAN B, Perrys M, Hinds A
   Sofosbuvir/Velpatasvir/Voxilaprevir for Previous Treatment Failures With Glecaprevir/Pibrentasvir in Chronic Hepatitis C Infection.
   Am J Gastroenterol. 2019 May 8. doi: 10.14309/ajg.0000000000000248.
   PubMed     Text format     Abstract available
   
   
   January 2019
3. LAIQUE SN, Vargas HE
   Hepatitis C Virus: No Longer a Barrier to Oncology Care.
   Am J Gastroenterol. 2019 Jan 18. doi: 10.14309/ajg.0000000000000095.
   PubMed     Text format     Abstract available
   
   
   November 2018
4. TORRES HA, Economides MP, Angelidakis G, Hosry J, et al
   Sofosbuvir-Based Therapy in Hepatitis C Virus-infected Cancer Patients: A Prospective Observational Study.
   Am J Gastroenterol. 2018 Nov 8. pii: 10.1038/s41395-018-0383.
   PubMed     Text format     Abstract available
   
   
   October 2018
5. WIELAND A, Kohli R
   Non-Alcoholic Steatohepatitis as a Growing Indication for Liver Transplantation: The Evolving Gender and Ethnic Trends.
   Am J Gastroenterol. 2018 Oct 23. pii: 10.1038/s41395-018-0373.
   PubMed     Text format     Abstract available
   
   
   
6. YEE HS, Burton MJ, Belperio PS, Morgan TR, et al
   The Veterans Affairs Hepatitis C Treatment Considerations.
   Am J Gastroenterol. 2018 Oct 12. pii: 10.1038/s41395-018-0231.
   PubMed     Text format    
   
   
   July 2018
7. REDMAN JS, Sterling RK
   Treating HCV in a Captive Audience: Eradication Efforts in the Prison Microenvironment.
   Am J Gastroenterol. 2018 Jul 24. pii: 10.1038/s41395-018-0201.
   PubMed     Text format     Abstract available
   
   
   
8. YOUNOSSI ZM
   Disparities in Access to Direct Acting Antiviral Regimens for Hepatitis C Virus (HCV): The Impact of Race and Insurance Status.
   Am J Gastroenterol. 2018 Jul 18. pii: 10.1038/s41395-018-0200.
   PubMed     Text format     Abstract available
   
   
   
9. ACHARYA C, Bajaj JS
   Current Management of Hepatic Encephalopathy.
   Am J Gastroenterol. 2018 Jul 13. pii: 10.1038/s41395-018-0179.
   PubMed     Text format     Abstract available
   
   
   June 2018
10. CUADRADO A, Llerena S, Cobo C, Pallas JR, et al
    Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm.
    Am J Gastroenterol. 2018 Jun 27. pii: 10.1038/s41395-018-0157.
    PubMed     Text format     Abstract available
    
    
    
11. KRAWCZYK M, Gaweda B, Kosnik A, Rejowski S, et al
    Successful DAA-Based Treatment of Hcv-Related Fibrosing Cholestatic Hepatitis After Liver Transplantation Due to a Fulminant Liver Failure.
    Am J Gastroenterol. 2018 Jun 21. pii: 10.1038/s41395-018-0078.
    PubMed     Text format    
    
    
    
12. NOUREDDIN M, Vipani A, Bresee C, Todo T, et al
    NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0088.
    PubMed     Text format     Abstract available
    
    
    April 2018
13. ZAMOR PJ, Vierling J, Ghalib R, Luketic V, et al
    Elbasvir/grazoprevir in black adults with hepatitis C virus infection: a pooled analysis of phase 2/3 clinical trials.
    Am J Gastroenterol. 2018 Apr 26. pii: 10.1038/s41395-018-0053.
    PubMed     Text format     Abstract available
    
    
    
14. PERRELLA A, Rinaldi L, Galeota-Lanza A, Izzi A, et al
    DAAs and long-term clinical outcome in hepatitis C: the panacea for all diseases still does not exist.
    Am J Gastroenterol. 2018 Apr 24. pii: 10.1038/s41395-018-0062.
    PubMed     Text format    
    
    
    March 2018
15. WONG RJ, Jain MK, Therapondos G, Shiffman ML, et al
    Race/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment.
    Am J Gastroenterol. 2018 Mar 9. pii: 10.1038/s41395-018-0033.
    PubMed     Text format     Abstract available
    
    
    December 2017
16. BUNCHORNTAVAKUL C, Reddy KR
    HCV Therapy in Decompensated Cirrhosis before or after Liver Transplantation: A Paradoxical Quandary.
    Am J Gastroenterol. 2017 Dec 5. pii: ajg2017435. doi: 10.1038/ajg.2017.
    PubMed     Text format    
    
    
    
17. NGUYEN MH, Trinh H, Do S, Nguyen T, et al
    Open Label Study of 8 vs. 12 Weeks of Ledipasvir/Sofosbuvir in Genotype 6 Treatment Naive or Experienced Patients.
    Am J Gastroenterol. 2017;112:1824-1831.
    PubMed     Text format     Abstract available
    
    
    November 2017
18. KWO PY, Shiffman ML, Bernstein DE
    The Cochrane Review Conclusion for Hepatitis C DAA Therapies is Wrong.
    Am J Gastroenterol. 2017 Nov 14. doi: 10.1038/ajg.2017.
    PubMed     Text format    
    
    
    
19. SOLLIMA S, Milazzo L, Antinori S, Galli M, et al
    Direct-Acting Antivirals and Mixed Cryoglobulinemia Vasculitis: Long-Term Outcome of Patients Achieving HCV Eradication.
    Am J Gastroenterol. 2017;112:1753-1754.
    PubMed     Text format    
    
    
    
20. LIU X, Shen JJ, Lee JL, Yoo JW, et al
    Cost-Effective but Unaffordable and Unequal Hepatitis C Treatment in the US.
    Am J Gastroenterol. 2017;112:1749.
    PubMed     Text format    
    
    
    
21. FUKUI N, Golabi P, Otgonsuren M, Mishra A, et al
    Demographics, Resource Utilization, and Outcomes of Elderly Patients With Chronic Liver Disease Receiving Hospice Care in the United States.
    Am J Gastroenterol. 2017;112:1700-1708.
    PubMed     Text format     Abstract available
    
    
    October 2017
22. WU T, Kwok RM, Tran TT
    Isolated anti-HBc: The Relevance of Hepatitis B Core Antibody-A Review of New Issues.
    Am J Gastroenterol. 2017 Oct 31. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available
    
    
    
23. KECK C, Shetty A, Mischen B, Willner I, et al
    Hepatic Splenosis Masquerading as Hepatocellular Carcinoma in a Chronic Hepatitis C Patient.
    Am J Gastroenterol. 2017;112:1493.
    PubMed     Text format    
    
    
    September 2017
24. KOFF RS
    Editorial: Direct Antiviral Agents Eliminate the Age Barrier to Treatment of Chronic Hepatitis C.
    Am J Gastroenterol. 2017;112:1410-1411.
    PubMed     Text format     Abstract available
    
    
    
25. LENS S, Fernandez I, Rodriguez-Tajes S, Hontangas V, et al
    Interferon-Free Therapy in Elderly Patients With Advanced Liver Disease.
    Am J Gastroenterol. 2017;112:1400-1409.
    PubMed     Text format     Abstract available
    
    
    August 2017
26. MARTIN P, Fabrizi F
    Editorial: Benefit of Direct-Acting Antiviral Therapy For Cryoglobulinemia due to Hepatitis C Infection.
    Am J Gastroenterol. 2017;112:1309-1310.
    PubMed     Text format     Abstract available
    
    
    
27. EMERY JS, Kuczynski M, La D, Almarzooqi S, et al
    Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia.
    Am J Gastroenterol. 2017;112:1298-1308.
    PubMed     Text format     Abstract available
    
    
    April 2017
28. LEE MH, Hsiao TI, Subramaniam SR, Le AK, et al
    HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.
    Am J Gastroenterol. 2017 Apr 25. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available
    
    
    
29. OOKA K, Connolly JJ, Lim JK
    Medicaid Reimbursement for Oral Direct Antiviral Agents for the Treatment of Chronic Hepatitis C.
    Am J Gastroenterol. 2017 Apr 4. doi: 10.1038/ajg.2017.
    PubMed     Text format    
    
    
    February 2017
30. TAKYAR V, Kleiner DE, Koh C
    A Wolf in Sheep's Clothing in the Era of Non-Invasive Staging: Non-Hodgkin's Lymphoma Masquerading as Serologic HCV Cirrhosis.
    Am J Gastroenterol. 2017;112:398-399.
    PubMed     Text format    
    
    
    
31. YANG JD, Mohamed HA, Cvinar JL, Gores GJ, et al
    Corrigendum: Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
    Am J Gastroenterol. 2017;112:402.
    PubMed     Text format    
    
    
    December 2016
32. PILLAI AA, Anania FA, Pearlman BL
    Caution: Reactivation of Hepatitis B during Hepatitis C Treatment with Direct-Acting Antiviral Therapy.
    Am J Gastroenterol. 2016;111:1854-1856.
    PubMed     Text format    
    
    
    August 2016
33. TROJAN J, Sarrazin C
    Complete Response of Hepatocellular Carcinoma in a Patient With End-stage Liver Disease treated With Nivolumab: Whishful thinking or Possible?
    Am J Gastroenterol. 2016;111:1208-9.
    PubMed     Text format    
    
    
    July 2016
34. DI COSTANZO GG, Marino Marsilia G, Tortora R, Di Costanzo G, et al
    Hepatocellular Carcinoma With Peliosis-Like Change-Mimicking Hemangioma: A LI-RADS Exception.
    Am J Gastroenterol. 2016;111:1038-40.
    PubMed     Text format    
    
    
    March 2016
35. SHI Y, Xia F, Li QJ, Li JH, et al
    Magnetic Resonance Elastography for the Evaluation of Liver Fibrosis in Chronic Hepatitis B and C by Using Both Gradient-Recalled Echo and Spin-Echo Echo Planar Imaging: A Prospective Study.
    Am J Gastroenterol. 2016 Mar 15. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: